Text
Addiction treatment providers’ engagements with the Brain Disease Model of Addiction
Debates about the etiology of addiction among
researchers and policymakers have a long history
and continue to the present day. In contemporary
societies within a range of nations, the brain disease
model of addiction (BDMA) has received strong
support. This has come, in particular, from US agencies such as the National Institute on Drug Abuse
(NIDA) and American Society of Addiction Medicine. Moreover, there continues to be a significant
investment in addiction neuroscience research globally. However, the views of addiction treatment providers about the BDMA, and its clinical impact and
relevance, are often relegated to the background
when lively debates led by public health researchers
and neuroscientists dominate discourse about the
neurobiology of addiction
No copy data
No other version available